Gilead Sciences Available-for-Sale Debt Securities - Amortized Cost (Due Within One Year) decreased by 21.1% to $15.00M in Q1 2026 compared to the prior quarter. This decline may warrant attention — for this metric, higher values are generally preferred.
Higher levels indicate strong short-term liquidity, while lower levels might suggest a reliance on other funding sources or a strategy to reinvest in longer-term assets.
This metric measures the amortized cost of available-for-sale debt securities that are scheduled to mature within one ye...
Standard metric for all financial institutions to demonstrate short-term solvency and cash flow management.
afs_debt_securities_amortized_cost_1y| Q2 '21 | Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q2 '25 | Q3 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $1.69B | $1.39B | $1.09B | $962.00M | $1.02B | $1.01B | $1.01B | $1.23B | $79.00M | $19.00M | $15.00M |
| QoQ Change | — | -17.6% | -21.5% | -11.8% | +5.8% | -1.2% | +0.8% | +21.6% | -93.6% | -75.9% | -21.1% |
| YoY Change | — | — | — | -43.0% | -26.8% | -7.8% | +5.4% | +21.1% | — | — | — |